3-Hexyltetrahydro-4-hydroxy-6-undecyl-2H-pyran-2-one

3-Hexyltetrahydro-4-hydroxy-6-undecyl-2H-pyran-2-one (CAS 104801-96-9) is a pharmaceutical-grade intermediate of orlistat, a drug used to treat obesity. It is manufactured directly by Hunan HuaTeng Pharmaceutical Co., Ltd., a supplier of pharmaceutical intermediates and PEG derivatives that also provides supportive technical documentation for R&D, evaluation, and commercial use, and is distributed across North America, Central/South America, Western and Eastern Europe, Australasia, and Asia.